Weed legalisation linked to drop in alcohol, tobacco consumption, study says

Business
May.19.2022
Weed legalisation linked to drop in alcohol, tobacco consumption, study says

Cannabis legalisation is linked to a reduction in alcohol and cigarette consumption, as well as pain medication misuse among young adults, a new study has suggested.

 

The research, published last week in the Journal of Adolescent Health, assessed trends in alcohol, nicotine, and non-prescribed pain reliever use in Washington State following the legalisation of cannabis for recreational use in 2012.

 

Scientists, including those from the University of Washington, analysed data from six annual waves of surveys from 2014 through 2019, covering 12,500 young adults of ages 18 to 25.

 

While previous studies have debunked the idea that cannabis is a so-called “gateway drug”, leading to the consumption of other, potentially more dangerous controlled substances, the new research 

confirms that cannabis legalisation does not lead to drastic increases in the use of alcohol and cigarettes or the misuse of non-prescribed opioids.

 

It found that the prevalence of past-month alcohol use, heavy episodic drinking (HED), and cigarette use and prevalence of past-year pain reliever misuse decreased among the cohort.

 

“Across years and age groups, the prevalence of substance use other than cannabis was higher among occasional and frequent cannabis users compared to cannabis non-users,” scientists wrote.

 

“Contrary to concerns about spillover effects, implementation of legalized nonmedical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse,” they added.

 

However, the study found that the prevalence of e-cigarette use among the cohort rose during the timeframe of the assessment, likely due to the overall growth in consumption of vapes during this period in the US and not necessarily linked to cannabis legalisation.

 

Previous research has also shown that legalising weed can help people depend less on alcohol and other controlled substances.

 

A study published earlier this year found that cannabis legalisation is linked to reduced use of prescription medication for treating anxiety, pain, sleep, as well as seizures.

 

Another study in 2019 also found that recreational and medical cannabis access laws reduce morphine use.

 

While the link between cannabis use and the consumption of other controlled substances needs further research, scientists say the new findings point to the increased significance of cannabis-specific prevention and treatment efforts.

 

Source:yahoo

Australia’s NSW Finds Lower Vaping Rates Among Teenagers Aged 14 to 17
Australia’s NSW Finds Lower Vaping Rates Among Teenagers Aged 14 to 17
A new report from Cancer Council’s Generation Vape research project shows that fewer teenagers in New South Wales are trying vaping after the state government introduced tougher vaping goods laws. Among surveyed NSW teenagers aged 14 to 17, the proportion who had tried vaping fell from 29.6% in April 2024 to 20.1% in October 2025.
Mar.17 by 2FIRSTS.ai
New Zealand Vape Company Alt Becomes Government Partner After Suing Over Nicotine Limits
New Zealand Vape Company Alt Becomes Government Partner After Suing Over Nicotine Limits
Health NZ signed a NZD 500,000 contract with New Zealand-owned vape company Alt NZ Limited in December 2025 for its free vape kit programme for smokers, with more than 7,000 kits distributed so far.
Mar.23 by 2FIRSTS.ai
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G said it plans to cancel all treasury shares it holds, totaling 10,866,189 shares, representing about 9.5% of shares outstanding, in line with Korea’s third amendment to the Commercial Act requiring companies to cancel repurchased shares within one year. The company also disclosed progress on its shareholder-return plan and multiple agenda items for next month’s shareholders meeting.
Feb.26
Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%
Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%
Casey’s General Stores (NASDAQ: CASY) reported accelerating growth in modern nicotine products during its fiscal third quarter ended January 31, 2026. Nicotine pouch sales increased 31% year over year, while vapor products rose 12%. Although cigarette unit sales continued to decline, management stated that the rate of decline slowed compared to prior quarters.
Market
Mar.15
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai
BAT Malaysia Launches Workforce Exercise to Improve Efficiency and Align With Future Business Direction
BAT Malaysia Launches Workforce Exercise to Improve Efficiency and Align With Future Business Direction
British American Tobacco Malaysia has announced a workforce optimisation exercise aimed at streamlining operations ahead of a major shift in its distribution strategy.
Apr.01 by 2FIRSTS.ai